SEARCH

SEARCH BY CITATION

References

  • 1
    Matsuo K,Kusano A,Sugumar A,Nakamura S,Tajima K,Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004; 95: 74552.
  • 2
    Dal ML,Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 207885.
  • 3
    Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295300.
  • 4
    Kayali Z,Buckwold VE,Zimmerman B,Schmidt WN. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002; 36: 97885.
  • 5
    Dammacco F,Sansonno D,Piccoli C,Tucci FA,Racanelli V. The cryoglobulins: an overview. Eur J Clin Invest 2001; 31: 62838.
  • 6
    Pileri P,Uematsu Y,Campagnoli S,Galli G,Falugi F,Petracca R,Weiner AJ,Houghton M,Rosa D,Grandi G,Abrignani S. Binding of hepatitis C virus to CD81. Science 1998; 282: 93841.
  • 7
    Rosa D,Saletti G,De GE,Zorat F,Comar C,D'Oro U,Nuti S,Houghton M,Barnaba V,Pozzato G,Abrignani S. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005; 102: 185449.
  • 8
    Machida K,Cheng KT,Sung VM,Shimodaira S,Lindsay KL,Levine AM,Lai MY,Lai MM. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 2004; 101: 42627.
  • 9
    Zignego AL,Giannelli F,Marrocchi ME,Mazzocca A,Ferri C,Giannini C,Monti M,Caini P,Villa GL,Laffi G,Gentilini P. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 2000; 31: 4749.
  • 10
    Zignego AL,Ferri C,Giannini C,La CL,Careccia G,Longombardo G,Bellesi G,Caracciolo F,Thiers V,Gentilini P. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997; 142: 54555.
  • 11
    Kitay-Cohen Y,Amiel A,Hilzenrat N,Buskila D,Ashur Y,Fejgin M,Gaber E,Safadi R,Tur-Kaspa R,Lishner M. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 2000; 96: 291012.
  • 12
    Monni O,Franssila K,Joensuu H,Knuutila S. BCL2 overexpression in diffuse large B-cell lymphoma. Leuk Lymphoma 1999; 34: 4552.
  • 13
    Yamasaki R,Yokota K,Okada H,Hayashi S,Mizuno M,Yoshino T,Hirai Y,Saitou D,Akagi T,Oguma K. Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue (MALT) lymphoma. J Med Microbiol 2004; 53 (Part 1): 219.
  • 14
    Engels EA,Cerhan JR,Linet MS,Cozen W,Colt JS,Davis S,Gridley G,Severson RK,Hartge P. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol 2005; 162: 115361.
  • 15
    Sung VM,Shimodaira S,Doughty AL,Picchio GR,Can H,Yen TS,Lindsay KL,Levine AM,Lai MM. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003; 77: 213446.
  • 16
    Munoz N,Bosch FX,De SS,Tafur L,Izarzugaza I,Gili M,Viladiu P,Navarro C,Martos C,Ascunce N. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52: 7439.
  • 17
    Donato F,Boffetta P,Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 34754.
  • 18
    Jaffee ES,Harris NL,Stein H,Vardiman JW. WHO classificatio of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
  • 19
    Gisbert JP,Garcia-Buey L,Pajares JM,Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 172332.
  • 20
    Mahieux R,Gessain A. HTLV-1 and associated adult T-cell leukemia/lymphoma. Rev Clin Exp Hematol 2003; 7: 33661.
  • 21
    Viejo-Borbolla A,Ottinger M,Schulz TF. Human herpesvirus 8: biology and role in the pathogenesis of kaposi's sarcoma and other aids-related malignancies. Curr Infect Dis Rep 2003; 5: 16975.
  • 22
    Giordano TP,Henderson L,Landgren O,Chiao EY,Kramer JR,El-Serag H,Engels EA. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 201017.
  • 23
    Hermine O,Lefrere F,Bronowicki JP,Mariette X,Jondeau K,Eclache-Saudreau V,Delmas B,Valensi F,Cacoub P,Brechot C,Varet B,Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 8994.
  • 24
    Vallisa D,Bernuzzi P,Arcaini L,Sacchi S,Callea V,Marasca R,Lazzaro A,Trabacchi E,Anselmi E,Arcari AL,Moroni C,Berte R, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol 2005; 23: 46873.
  • 25
    Engels EA,Frisch M,Lubin JH,Gail MH,Biggar RJ,Goedert JJ. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr 2002; 31: 53641.
  • 26
    Waters L,Stebbing J,Mandalia S,Young AM,Nelson M,Gazzard B,Bower M. Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study. Int J Cancer 2005; 116: 1613.
  • 27
    Franceschi S,Polesel J,Rickenbach M,Dal ML,Probst-Hensch NM,Fux C,Cavassini M,Hasse B,Kofler A,Ledergerber B,Erb P,Clifford GM. Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV cohort study. Br J Cancer 2006; 95: 1598602.
  • 28
    Morton LM,Landgren O,Chatterjee N,Castenson D,Parsons R,Hoover RN,Engels EA. Hepatitis C virus infection and risk of post-transplant lymphoproliferative disorder among solid organ transplant recipients. Blood 2007; 110: 4599605.